3D Systems announces its creation – GuruFocus.com
ROCK HILL, South Carolina, May 16, 2022 (GLOBE NEWSWIRE) — Today, 3D Systems (:DDD) announced the formation of the company’s first Medical Advisory Board (MAB) and the appointment of Stephen K. Klasko, MD, MBA as President. MAB’s primary mission will be to provide strategic information, advice and recommendations for society’s emerging efforts in regenerative medicine as they begin to move from research to advanced development and ultimately to application. human. The MAB will include a wide range of skills and experience ranging from scientific expertise to commercial application, including advice on forming key partnerships to reduce program risk and accelerate the achievement of program objectives.
Dr. Klasko, who will be the first president of MAB, is one of the most respected executives in the healthcare industry today, known for bridging the entrepreneurial spirit of Silicon Valley with the current healthcare ecosystem. Most recently, he led Jefferson Health to become one of the fastest growing academic health centers in the United States, serving as President and CEO of Thomas Jefferson University and Jefferson Health. During Dr. Klasko’s eight-year tenure, Jefferson grew from approximately $1 billion in revenue to more than $9 billion, dramatically expanding the institution’s capabilities and reach – establishing one of largest and most advanced telemedicine faculty in the country to bring health care to millions of people in need.
During his accomplished career, Dr. Klasko has served as dean of two medical schools and CEO of three health systems. He is deeply committed to transforming healthcare from its traditional focus on “healthcare” to a resilient and proactive “healthcare at any address” system – designed to bend the cost curve through the innovation, making quality care more accessible and displacing the population. health, social determinants and predictive analytics, from philosophical exercises to mainstream clinical care and payment models. Dr. Klasko is one of the nation’s leading voices, championing the transformation of health systems in partnership with digital technology innovators in pursuit of a very different and better future.
Commenting on the creation of the MAB and the appointment of Dr. Klasko, Dr. Jeffrey Graves, President and CEO of 3D Systems, said: “This is a pivotal time in the history of our company where every day we can see more clearly the potential of regenerative medicine to positively impact humanity and the key role our bioprinting technology can play in humanity’s future. MAB will provide key information, advice and support to make this vision a reality. We are blessed by Dr. Klasko’s willingness to chair this group and help guide its formation and operation. Steve is an inspirational leader who articulates a compelling vision for the healthcare industry, including the transformative potential of medical technology to improve patient outcomes, expand access and reduce medical costs. He embodies a deep passion for entrepreneurship and inclusiveness that has yielded remarkable results throughout his career. In recognition of his achievements, he was named in 2020 by the World Economic Forum as its inaugural Distinguished Fellow, in which he provided key insights to business and political leaders on the future of healthcare and healthcare. digital economy at their annual meetings held in Davos, Switzerland. Under Steve’s leadership, we look forward to expanding MAB in the future as our efforts continue to grow. »
In addition to being the author of five books, numerous articles and blogs, Dr. Most Influential” from Modern Healthcare, Fast Company’s Most Creative People in Business, Ernst & Young’s 2018 “Entrepreneur of the Year” and “100 Great Leaders in Healthcare” from Becker’s Hospital Review.
Since retiring from Jefferson Health earlier this year, Dr. Klasko has taken on the role of Executive-in-Residence for General Catalyst, where he is implementing the “health insurance” model based on the book that he wrote with Hemant Taneja, Managing Partner of GC , titled “UnHealthcare: A Manifesto for Health Insurance”. Since 2008, Dr. Klasko has also been a director of Teleflex (:TFX) where he served on the governance and audit committees.
Certain statements made in this release that are not statements of historical or current fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors. which may cause the company’s actual results, performance or achievements to be materially different from historical results or any future results or projections expressed or implied by such forward-looking statements. In many cases, forward-looking statements can be identified by words such as “believes”, “believes”, “expects”, “may”, “will”, “estimates”, “intends”. , “anticipate” or “plan” or the negative of these terms or other comparable terms. Forward-looking statements are based on management’s current beliefs, assumptions and expectations and may include comments about the company’s beliefs and expectations regarding future events and trends affecting its business and are necessarily subject to uncertainties, including many are beyond the company’s control. The factors described under the headings “Forward-Looking Statements” and “Risk Factors” in the company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or anticipated in the forward-looking statements. research statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, the forward-looking statements are not and should not be taken as guarantees of future performance or results, and they will not necessarily prove to be precise indications. the times at which these performances or results will be achieved. The forward-looking statements included are made only as of the date of the statement. 3D Systems undertakes no obligation to update or revise any forward-looking statements made by or on behalf of management, whether as a result of future developments, subsequent events or circumstances or otherwise, except as required by law. requires it.
About 3D Systems
Over 30 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing industry. Today, as the leading additive manufacturing solutions partner, we bring innovation, performance and reliability to every interaction – enabling our customers to create products and business models never before possible. Through our unique offering of hardware, software, materials and services, each application-specific solution is powered by the expertise of our application engineers who work with customers to transform the way they deliver their products and services. 3D Systems’ solutions serve a variety of advanced applications in healthcare and industrial markets such as medical and dental, aerospace and defense, automotive, and durable goods. More information about the company is available at www.3dsystems.com.
Investor contacts: [email protected]
Media Contact: [email protected]
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/eca37f69-0731-476f-b324-9f6d586b9855